News
LIVN
64.99
+0.63%
0.41
Mizuho Securities Remains a Buy on LivaNova (LIVN)
TipRanks · 1d ago
Weekly Report: what happened at LIVN last week (0406-0410)?
Weekly Report · 1d ago
Weekly Report: what happened at LIVN last week (0330-0403)?
Weekly Report · 04/06 09:10
Weekly Report: what happened at LIVN last week (0323-0327)?
Weekly Report · 03/30 09:10
How FDA Approval of Aura6000 Sleep Apnea Therapy Will Impact LivaNova (LIVN) Investors
Simply Wall St · 03/29 05:03
LivaNova schedules a conference call on first-quarter FY2026 results; access code set at 946097
Reuters · 03/25 13:02
A Look At LivaNova (LIVN) Valuation After Recent Share Price Weakness
Simply Wall St · 03/24 22:09
Weekly Report: what happened at LIVN last week (0316-0320)?
Weekly Report · 03/23 09:10
LivaNova’s Aura6000 FDA Win Reshapes Obstructive Sleep Apnea Opportunity
Simply Wall St · 03/21 05:06
Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT) and LivaNova (LIVN)
TipRanks · 03/19 15:00
LivaNova gains FDA premarket approval for aura6000 for sleep apnea
Seeking Alpha · 03/19 14:58
LivaNova granted premarket approval for aura6000 System by FDA
TipRanks · 03/19 12:42
LivaNova Receives FDA Premarket Approval For aura6000 System For Treatment Of Adult Patients With Moderate To Severe Obstructive Sleep Apnea
Benzinga · 03/19 12:39
LivaNova wins FDA PMA approval for aura6000 obstructive sleep apnea system
Reuters · 03/19 12:31
Strength Seen in Tandem Diabetes Care (TNDM): Can Its 9.1% Jump Turn into More Strength?
NASDAQ · 03/18 10:18
Weekly Report: what happened at LIVN last week (0309-0313)?
Weekly Report · 03/16 09:10
Weekly Report: what happened at LIVN last week (0302-0306)?
Weekly Report · 03/09 09:10
Assessing LivaNova (LIVN) Valuation After Strong One Year Shareholder Returns
Simply Wall St · 03/05 22:35
Artisan International Small-Mid Fund Q4 2025 Performance Review
Seeking Alpha · 03/02 18:38
Weekly Report: what happened at LIVN last week (0223-0227)?
Weekly Report · 03/02 09:10
More
Webull provides a variety of real-time LIVN stock news. You can receive the latest news about Livanova Plc through multiple platforms. This information may help you make smarter investment decisions.
About LIVN
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.